Avantika Kakkar, is a Partner at Cyril Amarchand Mangaldas & Co., she was lead lawyer in the first Phase II merger control case in India (Sun Pharma/Ranbaxy) and in the first few cases involving remedies (Hospira/Orchid, ZF Friedrichshafen AG/TRW Automotive) at the CCI. She argued mitigated damages for Titan International, Inc. and secured a zero-penalty order for Grupo Isolux Corsán for delayed merger filings.

Her practice includes strategic advice for her clients in merger defence and enforcement as well as leading third-party objections to certain mergers before the CCI.

Her experience in Indian corporate and securities laws, transactional work in M&A, private equity, joint ventures, and structured finance equips her uniquely for strategy on merger regulation. She was among the first Indian lawyers to start practicing Indian Competition law in 2009, when the law came into effect.